15. Peptides and Polypeptides as Immunomodulators and Their Consequential Therapeutic Effect in Multiple Sclerosis and Other Autoimmune Diseases

  1. Prof. Dr. Miguel Castanho and
  2. Prof. Dr. Nuno C. Santos
  1. Ruth Arnon,
  2. Michael Sela and
  3. Rina Aharoni

Published Online: 17 OCT 2011

DOI: 10.1002/9783527636730.ch15

Peptide Drug Discovery and Development: Translational Research in Academia and Industry

Peptide Drug Discovery and Development: Translational Research in Academia and Industry

How to Cite

Arnon, R., Sela, M. and Aharoni, R. (2011) Peptides and Polypeptides as Immunomodulators and Their Consequential Therapeutic Effect in Multiple Sclerosis and Other Autoimmune Diseases, in Peptide Drug Discovery and Development: Translational Research in Academia and Industry (eds M. Castanho and N. C. Santos), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527636730.ch15

Editor Information

  1. University of Lisbon, Institute of Biochemistry, Av. Egas Moniz, 1649-028 Lisboa, Portugal

Author Information

  1. Weizmann Institute of Science, Department of Immunology, PO Box 26, 76100 Rehovot, Israel

Publication History

  1. Published Online: 17 OCT 2011
  2. Published Print: 5 OCT 2011

ISBN Information

Print ISBN: 9783527328918

Online ISBN: 9783527636730

SEARCH

Keywords:

  • antigens;
  • therapeutic vaccines;
  • Copolymer 1 (Cop 1);
  • inflammation;
  • neuroprotection

Summary

This chapter contains sections titled:

  • Introduction

  • Peptides as Antigens and Vaccines

  • Peptides as Immunomodulators

  • Development of Copolymer 1 – a Polypeptide Immunomodulator Drug for the Treatment of Multiple Sclerosis

  • Additional Immunomodulatory Peptides as Drug Candidates

  • Summary and Concluding Remarks